A Multifunctional Antibacterial and Osteogenic Nanomedicine: QAS-Modified Core-Shell Mesoporous Silica Containing Ag
Dexiong Li1, Yubei Qiu2, Sihui Zhang2
1School and Hospital of Stomatology, Fujian Medical University, Fuzhou, Fujian 350000, China.
Biomed Research International
|October 5, 2020
Summary
Researchers developed silver-containing quaternary ammonium salt-modified mesoporous silica nanoparticles (Ag@QHMS) to combat bone infections. These nanoparticles eliminate bacteria and promote new bone tissue growth, offering a promising dual-action treatment for infectious bone defects.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Regenerative Medicine
- Infectious Diseases
Background:
- Infectious bone defects, like periodontitis, require treatments with both antibacterial and bone-regenerating properties.
- Nanomaterials offer multifunctional capabilities for developing advanced therapeutic agents.
- Current treatments often lack the dual efficacy needed for complex bone lesions.
Purpose of the Study:
- To synthesize and characterize a novel nanoparticle with combined antibacterial and osteogenic differentiation capabilities.
- To evaluate the efficacy of the synthesized nanoparticle against common periodontal pathogens.
- To assess the nanoparticle's potential to stimulate new bone tissue regeneration and mineralization.
Main Methods:
- Synthesis of silver-containing quaternary ammonium salt-modified hierarchical mesoporous silica nanoparticles (Ag@QHMS) via hydrothermal method and surface functionalization.
- In vitro evaluation of antibacterial activity against *Staphylococcus aureus*, *Escherichia coli*, and *Porphyromonas gingivalis* biofilms.
- Assessment of cytotoxicity, apoptosis, and osteogenic differentiation in bone mesenchymal stem cells (BMSCs).
Main Results:
- Ag@QHMS demonstrated sustained release of silver ions (Ag+) and a functionalized mesoporous structure.
- Ag@QHMS exhibited concentration-dependent antimicrobial efficacy, with a minimum inhibitory concentration below the biocompatible limit for BMSCs.
- The nanoparticles promoted osteogenic differentiation in BMSCs, indicated by increased expression of key osteogenic markers (RUNX2, ALP, OPN, OCN, BSP, COL-1) and enhanced matrix mineralization.
Conclusions:
- Ag@QHMS possesses dual antibacterial action through direct contact killing by quaternary ammonium salt (QAS) and sustained silver ion release.
- The nanoparticles are biocompatible at effective concentrations and actively promote osteogenic differentiation.
- This multifunctional nanomaterial shows significant potential for treating complex infectious bone defects by simultaneously clearing pathogens and regenerating bone tissue.
